X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (455) 455
disease-specific survival (353) 353
female (297) 297
male (296) 296
middle aged (283) 283
aged (259) 259
oncology (257) 257
prognosis (202) 202
adult (197) 197
cancer (182) 182
surgery (154) 154
aged, 80 and over (151) 151
survival (120) 120
disease-free survival (109) 109
neoplasm staging (100) 100
retrospective studies (98) 98
analysis (95) 95
risk factors (89) 89
treatment outcome (87) 87
disease-specific mortality (85) 85
carcinoma (83) 83
survival rate (83) 83
survival analysis (71) 71
care and treatment (69) 69
overall survival (65) 65
research (65) 65
proportional hazards models (64) 64
kaplan-meier estimate (61) 61
medicine & public health (60) 60
metastasis (56) 56
mortality (56) 56
disease specific survival (55) 55
epidemiology (55) 55
tumors (55) 55
young adult (55) 55
patient outcomes (54) 54
otorhinolaryngology (53) 53
adenocarcinoma (51) 51
chemotherapy (51) 51
follow-up studies (51) 51
recurrence (51) 51
disease‐specific survival (50) 50
multivariate analysis (50) 50
prostate cancer (50) 50
nutrition intervention trials (48) 48
risk (48) 48
cohort studies (46) 46
radiotherapy (46) 46
urology & nephrology (46) 46
medical prognosis (44) 44
health aspects (43) 43
lymphatic metastasis (43) 43
nomogram (43) 43
adolescent (42) 42
diagnosis (42) 42
breast cancer (41) 41
quality of life (40) 40
nomograms (39) 39
seer (39) 39
incidence (38) 38
squamous-cell carcinoma (38) 38
abridged index medicus (37) 37
medical research (37) 37
cancer patients (35) 35
hematology, oncology and palliative medicine (35) 35
management (35) 35
seer program (35) 35
stomach neoplasms - pathology (34) 34
expression (33) 33
stomach neoplasms - surgery (32) 32
therapy (32) 32
resection (31) 31
squamous cell carcinoma (31) 31
combined modality therapy (30) 30
immunohistochemistry (30) 30
outcomes (30) 30
radical prostatectomy (30) 30
medicine, research & experimental (29) 29
time factors (29) 29
united states - epidemiology (29) 29
child (28) 28
medicine, experimental (28) 28
quality-of-life (28) 28
risk assessment (28) 28
stomach cancer (28) 28
stomach neoplasms - mortality (28) 28
breast neoplasms - pathology (27) 27
pathology (27) 27
patients (27) 27
radiation therapy (27) 27
age (26) 26
carcinoma, squamous cell - pathology (26) 26
impact (26) 26
oncology, experimental (26) 26
prospective studies (26) 26
radiation-therapy (26) 26
adenocarcinoma - mortality (25) 25
head (25) 25
neoplasm grading (25) 25
prognostic-factors (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (625) 625
Japanese (9) 9
German (8) 8
Chinese (5) 5
French (2) 2
Korean (2) 2
Spanish (2) 2
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Lichtenberg, Tara and Lazar, Alexander J and Cherniack, Andrew D and Kovatich, Albert J and Benz, Christopher C and Levine, Douglas A and Omberg, Larsson and Wolf, Denise M and Shriver, Craig D and Thorsson, Vesteinn and Hu, Hai and Caesar-Johnson, Samantha J and Demchok, John A and Felau, Ina and Kasapi, Melpomeni and Ferguson, Martin L and Tarnuzzer, Roy and Wang, Zhining and Zenklusen, Jean C and Zhang, Jiashan (Julia) and Liu, Jia and Lolla, Laxmi and Naresh, Rashi and Pihl, Todd and Sun, Qiang and Wu, Ye and Cho, Juok and DeFreitas, Timothy and Frazer, Scott and Gehlenborg, Nils and Getz, Gad and Kim, Jaegil and Lawrence, Michael S and Meier, Sam and Voet, Doug and Zhang, Hailei and Chambwe, Nyasha and Dhankani, Varsha and Knijnenburg, Theo and Kramer, Roger and Miller, Michael and Reynolds, Sheila and Shmulevich, Ilya and Akbani, Rehan and Broom, Bradley M and Kanchi, Rupa S and Korkut, Anil and Li, Jun and Liang, Han and Ling, Shiyun and Mills, Gordon B and Rao, Arvind and Ryan, Michael and Wang, Jing and Weinstein, John N and Zhang, Jiexin and Abeshouse, Adam and Armenia, Joshua and Chakravarty, Debyani and Chatila, Walid K and de Bruijn, Ino and Gao, Jianjiong and Gross, Benjamin E and Kundra, Ritika and Ladanyi, Marc and Luna, Augustin and Nissan, Moriah G and Ochoa, Angelica and Phillips, Sarah M and Reznik, Ed and Sander, Chris and Sheridan, Robert and Taylor, Barry S and Wang, Jioajiao and Peto, Myron and Spellman, Paul and Wilkerson, Matthew D and Brooks, Denise and Chuah, Eric and Dhalla, Noreen and Holt, Robert and Jones, Steven J.M and Lee, Darlene and Marra, Marco A and Moore, Richard A and Mungall, Andrew J and Mungall, Karen and Robertson, A. Gordon and Sadeghi, Sara and Schein, Jacqueline E and Sipahimalani, Payal and Tam, Angela and Thiessen, Nina and Tse, Kane and Wong, Tina and Beroukhim, Rameen and Gao, Galen F and Ha, Gavin and Meyerson, Matthew and Schumacher, Steven E and ... and The Cancer Genome Atlas Research Network and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
Cell (Cambridge), ISSN 0092-8674, 04/2018, Volume 173, Issue 2, pp. 400 - 416.e11
Journal Article
Diseases of the Colon & Rectum, ISSN 0012-3706, 09/2018, Volume 61, Issue 9, pp. 1053 - 1062
Journal Article
by Liu, CQ and Li, HY and Zhuo, R and Wang, LJ and He, LH and Ruan, QQ and Luan, XY and Mo, XJ and Sun, Y
MEDICINE, ISSN 0025-7974, 07/2019, Volume 98, Issue 28, p. e16436
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2012, Volume 30, Issue 31, pp. 3834 - 3840
Journal Article
The lancet oncology, ISSN 1470-2045, 2009, Volume 10, Issue 11, pp. 1045 - 1052
Summary Background Adjuvant imatinib mesylate prolongs recurrence-free survival (RFS) after resection of localised primary gastrointestinal stromal tumours... 
Hematology, Oncology and Palliative Medicine | DISEASE-SPECIFIC SURVIVAL | ONCOLOGY | C-KIT MUTATION | POOR-PROGNOSIS | RISK STRATIFICATION | GASTRIC-CARCINOMA | MUSCLE TUMORS | RADICAL PROSTATECTOMY | POSTOPERATIVE NOMOGRAM | IMATINIB MESYLATE | NIH CONSENSUS CRITERIA | Predictive Value of Tests | United States - epidemiology | Gastrointestinal Stromal Tumors - secondary | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Patient Selection | Young Adult | Time Factors | Nomograms | Aged, 80 and over | Adult | Female | Registries | Retrospective Studies | Chemotherapy, Adjuvant | Gastrointestinal Stromal Tumors - mortality | Child | Reproducibility of Results | Gastrointestinal Stromal Tumors - surgery | Risk Assessment | Neoplasm Invasiveness | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Piperazines - therapeutic use | Imatinib Mesylate | Disease-Free Survival | Mitotic Index | Digestive System Surgical Procedures | Gastrointestinal Stromal Tumors - drug therapy | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Spain - epidemiology | Adolescent | Aged | Benzamides | Neoplasm Staging | Sarcoma | Surgery | Singers | recurrence | GIST | gastrointestinal stromal tumor | survival | nomogram | imatinib mesylate | prognosis | staging | surgery
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2016, Volume 34, Issue 23, pp. 2721 - 2727
Journal Article
Pigment Cell & Melanoma Research, ISSN 1755-1471, 03/2016, Volume 29, Issue 2, pp. 176 - 185
Journal Article
International journal of cancer, ISSN 0020-7136, 2016, Volume 139, Issue 12, pp. 2730 - 2737
Journal Article
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2014, Volume 211, Issue 6, pp. 627.e1 - 627.e9
Objective There are known disparities in endometrial cancer survival with black women who experience a greater risk of death compared with white women... 
Obstetrics and Gynecology | endometrial cancer | racial disparity | comorbid condition | disease-specific survival | hypertension | UTERINE CORPUS | RACIAL/ETHNIC DIFFERENCES | TUMORS | EPITHELIAL OVARIAN-CANCER | AFRICAN-AMERICAN | OBSTETRICS & GYNECOLOGY | BLOCKERS | IMPACT | RACE | WHITE WOMEN | Endometrial Neoplasms - ethnology | Adenocarcinoma, Clear Cell - ethnology | Prognosis | Endometrial Neoplasms - mortality | Health Status Disparities | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Adenocarcinoma, Mucinous - epidemiology | Protective Factors | Carcinoma, Endometrioid - ethnology | Female | Retrospective Studies | Adenocarcinoma - ethnology | Hypertension - epidemiology | Adenocarcinoma, Mucinous - ethnology | Carcinoma, Endometrioid - epidemiology | Adenocarcinoma, Clear Cell - epidemiology | Comorbidity | Risk Factors | Proportional Hazards Models | European Continental Ancestry Group - statistics & numerical data | Endometrial Neoplasms - epidemiology | Adenocarcinoma, Mucinous - mortality | Disease-Free Survival | African Americans - statistics & numerical data | Carcinoma, Endometrioid - mortality | Diabetes Mellitus - epidemiology | Obesity - epidemiology | Aged | Adenocarcinoma - epidemiology | Adenocarcinoma - mortality | Cohort Studies | African Americans | GABA | Family medicine | Endometrial cancer | Ford, Henry (American automotive executive)
Journal Article